Fuso Pharmaceutical Industries,Ltd. [4538.T]
TOKYO, May 12 (Pulse News Wire) – Fuso Pharmaceutical Industries,ltd. (4538.T) announced changes to its board and executive leadership effective May 12, 2026.
The company said that Okajunichi, currently serving as Executive Director of Production Headquarters, will retire. Additionally, Yuasa Kazuaki's role was elevated from Executive Officer Deputy Head of Production Headquarters to Senior Executive Officer and Head of Production Headquarters, effective June 24, 2026.
These appointments reflect the ongoing strategic realignment within the organization aimed at enhancing operational efficiency and production capabilities. The changes come as part of the company’s broader efforts to strengthen its management structure and drive future growth initiatives.
🟡 Confidence: Standard AI-translated content.